株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

過活動膀胱治療 (OBT) の世界市場:2024年までの予測

Global Overactive Bladder Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

発行 QYResearch 商品コード 913584
出版日 ページ情報 英文 83 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
過活動膀胱治療 (OBT) の世界市場:2024年までの予測 Global Overactive Bladder Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
出版日: 2019年10月10日 ページ情報: 英文 83 Pages
概要

世界における過活動膀胱治療 (OBT) 市場規模は2018年の50億9,520万米ドルから2025年末までに58億6,970万米ドルへ達すると予測され、2019年から2025年にかけては2.97%のCAGR (年間複合成長率) が見込まれています。

当レポートでは、世界の過活動膀胱治療 (OBT) 市場を調査し、市場の定義と概要、市場規模の推移と予測、企業・種類・病因別の詳細分析、将来予測、および主要企業のプロファイルなどをまとめています。

第1章 調査概要

  • 調査範囲
  • 主な市場区分
  • 対象企業
  • 市場分析:種類別
    • 世界市場規模の成長率:種類別
    • 医薬品
    • 装置
  • 市場:病因別
  • 調査目的
  • 対象年

第2章 世界の成長動向

  • 世界の過活動膀胱治療 (OBT) 市場規模
  • 過活動膀胱治療 (OBT) の成長動向:地域別
  • 産業動向

第3章 市場シェア:主要企業別

  • 過活動膀胱治療 (OBT) 市場規模:企業別
  • 主要企業の本部・対象地域
  • 主要企業の製品/ソリューション/サービス
  • 市場参入日

第4章 分析データ:種類別

  • 世界の過活動膀胱治療 (OBT) 市場規模:種類別
  • 世界の過活動膀胱治療 (OBT) 市場規模:病因別
  • 世界の過活動膀胱治療 (OBT) 市場:地域・年齢別
    • 有病率:地域・年齢別
    • 診断率:地域・年齢別
    • 平均医療費:地域別
    • 医療費に占める医療機器の平均シェア (金額ベース)
    • 医療費に占める医療機器の平均シェア (患者数)
  • 医薬品・医療機器の価格

第5章 米国

  • 市場
  • 主要企業
  • 市場規模:種類別
  • 市場規模:病因別
  • 治療項目/規制/ガイドライン

第6章 英国

第7章 ドイツ

第8章 フランス

第9章 スペイン

第10章 中国

第11章 オーストラリア

第12章 主要企業のプロファイル

  • Astellas Pharma
  • Allergan
  • Pfizer
  • Johnson & Johnson
  • Medtronic
  • Kyorin Pharmaceutical

第13章 市場予測

  • 市場規模予測:地域別
  • 米国
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • 中国
  • オーストラリア
  • 市場規模予測:製品別
  • 市場規模予測:病因別

第14章 アナリストの視点/結論

第15章 付録

図表

List of Tables and Figures

  • Table Overactive Bladder Treatment Key Market Segments
  • Table Overactive Bladder Treatment Key Players Covered in 2018
  • Table Global Overactive Bladder Treatment Market Size Growth Rate by Type (2019-2025) (Million US$)
  • Figure Global Overactive Bladder Treatment Market Share by Type in 2018
  • Figure Drugs Features
  • Table of Key Players of Drugs
  • Figure Device Features
  • Table of Key Players of Device
  • Table Global Overactive Bladder Treatment Market Size Growth by Cause (2019-2025) (Million US$)
  • Figure Global Overactive Bladder Treatment Market Share by Cause in 2018
  • Figure Overactive Bladder Treatment Report Years Considered
  • Figure Global Overactive Bladder Treatment Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Overactive Bladder Treatment Market Size by Regions 2019-2025 (Million US$)
  • Figure Global Overactive Bladder Treatment Market Size by Regions 2019-2025 (Million US$)
  • Table Global Overactive Bladder Treatment Market Size by Regions 2014-2019 (Million US$)
  • Table Global Overactive Bladder Treatment Market Share by Regions 2014-2019
  • Figure Global Overactive Bladder Treatment Market Share by Regions 2014-2019
  • Figure Global Overactive Bladder Treatment Market Share by Regions 2018
  • Table Market Top Trends
  • Table Key Drivers: Impact Analysis (2019-2025)
  • Table Key Challenges
  • Figure Porter's Five Forces Analysis
  • Table Global Overactive Bladder Treatment Revenue by Players (2018-2019) (Million US$)
  • Table Global Overactive Bladder Treatment Market Share by Players (2018-2019)
  • Figure Global Overactive Bladder Treatment Market Share by Players in 2018
  • Table Global Overactive Bladder Treatment Players Market Concentration Ratio (CR5)
  • Table Key Players Head office and Area Served
  • Table Key Players Overactive Bladder Treatment Product/Solution/Service
  • Table Date of Enter into Overactive Bladder Treatment Market
  • Table Global Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Global Overactive Bladder Treatment Market Size Share by Type (2014-2019)
  • Figure Global Overactive Bladder Treatment Market Size Market Share by Type (2014-2019)
  • Table Global Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table Global Overactive Bladder Treatment Market Size Share by Cause (2014-2019)
  • Figure Global Overactive Bladder Treatment Market Size Market Share by Cause (2014-2019)
  • Figure Global Overactive Bladder Treatment Revenue Market Share by Cause in 2018
  • Table Global Overactive Bladder Prevalence Rate by Regions and Age
  • Table Global Overactive Bladder Diagnosis Rate by Regions and Age
  • Table Global Overactive Bladder Treatment Rate by Regions and Age
  • Table Global Overactive Bladder Average Cost (USD) by Regions 2014-2019
  • Table Global Overactive Bladder Average Share of Medical Devices (Value Basis) of Medical Expense 2014-2019
  • Table Global Overactive Bladder Average Share of Medical Devices (Patient Number Basis) of Medical Expense 2014-2019
  • Figure United States Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table United States Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table United States Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table United States Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table United States Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table United States Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table United States Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Table United States Overactive Bladder Treatment Article/Regulation/Guideline
  • Figure UK Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table UK Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table UK Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table UK Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table UK Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table UK Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table UK Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Table UK Overactive Bladder Treatment Article/Regulation/Guideline
  • Figure Germany Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table Germany Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table Germany Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table Germany Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Germany Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table Germany Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table Germany Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Figure France Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table France Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table France Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table France Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table France Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table France Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table France Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Table France Overactive Bladder Treatment Article/Regulation/Guideline
  • Figure Spain Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table Spain Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table Spain Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table Spain Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Spain Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table Spain Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table Spain Overactive Bladder Treatment Market Share by Application (2014-2019)
  • Figure Germany Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table China Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table China Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table China Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table China Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table China Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table China Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Figure Australia Overactive Bladder Treatment Market Size 2014-2019 (Million US$)
  • Table Australia Key Players Overactive Bladder Treatment Revenue (2018-2019) (Million US$)
  • Table Australia Key Players Overactive Bladder Treatment Market Share (2018-2019)
  • Table Australia Overactive Bladder Treatment Market Size by Type (2014-2019) (Million US$)
  • Table Australia Overactive Bladder Treatment Market Share by Type (2014-2019)
  • Table Australia Overactive Bladder Treatment Market Size by Cause (2014-2019) (Million US$)
  • Table Australia Overactive Bladder Treatment Market Share by Cause (2014-2019)
  • Table Australia Overactive Bladder Treatment Article/Regulation/Guideline
  • Table Astellas Pharma Company Details
  • Table Overactive Bladder Treatment Information of Astellas Pharma (Vesicare)
  • Table Overactive Bladder Treatment Information of Astellas Pharma (Betanis / Myrbetriq / BETMIGA)
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Astellas Pharma (2018-2019)
  • Table Allergan Company Details
  • Table Overactive Bladder Treatment Information of Allergan (Botox)
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Allergan (2018-2019)
  • Table Pfizer Company Details
  • Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
  • Table Overactive Bladder Treatment Information of Pfizer (Toviaz)
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Pfizer (2018-2019)
  • Table Johnson & Johnson Company Details
  • Table Overactive Bladder Treatment Information of Johnson & Johnson (Ditropan and Ditropan XL)
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Johnson & Johnson (2018-2019)
  • Table Medtronic Company Details
  • Table Overactive Bladder Treatment Information of Medtronic (InterStim System)
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Medtronic (2018-2019)
  • Table Kyorin Pharmaceutical Company Details
  • Table Overactive Bladder Treatment Information of Kyorin Pharmaceutical
  • Table Overactive Bladder Treatment Revenue (M USD) and Gross Margin of Kyorin Pharmaceutical (2018-2019)
  • Table Global Overactive Bladder Treatment Market Size by Regions (Million US$) 2019-2025
  • Figure Global Overactive Bladder Treatment Market Size Share by Regions (2019-2025)
  • Figure Global Overactive Bladder Treatment Market Size Share by Regions in 2025
  • Figure United States Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure UK Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure Germany Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure France Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure Spain Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure China Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Figure Australia Overactive Bladder Treatment Market Size Forecast (2019-2025) (Million USD)
  • Table Global Overactive Bladder Treatment Market Size by Product (2019-2025) (Million USD)
  • Figure Global Overactive Bladder Treatment Market Size by Product (2019-2025)
  • Figure Global Overactive Bladder Treatment Market Size by Product in 2025
  • Table Global Overactive Bladder Treatment Market Size by Cause (2019-2025) (Million USD)
  • Figure Global Overactive Bladder Treatment Market Size by Cause (2019-2025)
  • Figure Global Overactive Bladder Treatment Market Size by Cause in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Figure Key Executives Interviewed
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

In 2018, the global Overactive Bladder Treatment market size was 5095.2 million US$ and it is expected to reach 5869.7 million US$ by the end of 2025, with a CAGR of 2.97% during 2019-2025.

This report focuses on the global Overactive Bladder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Treatment development in United States, UK, Germany, France, Spain, Australia and Other Regions

The key players covered in this study:

  • Allergan
  • Astellas Pharma
  • Pfizer
  • Johnson & Johnson
  • Medtronic
  • KYORIN Pharmaceutical

Market segment by Type, the product can be split into:

  • Drugs
  • Device

Market segment by Cause, split into:

  • Idiopathic Overactive Bladder
  • Neurogenic Overactive Bladder

Market segment by Regions/Countries, this report covers:

  • United States
  • UK
  • Germany
  • France
  • Spain
  • Germany
  • Australia
  • Other Regions

Table of Contents

1. Report Overview

  • 1.1. Study Scope
  • 1.2. Key Market Segments
  • 1.3. Players Covered
  • 1.4. Market Analysis by Type
    • 1.4.1. Global Overactive Bladder Treatment Market Size Growth Rate by Type (2019-2025)
    • 1.4.2. Drugs
    • 1.4.3. Device
  • 1.5. Market by Cause
  • 1.6. Study Objectives
  • 1.7. Years Considered

2. Global Growth Trends

  • 2.1. Global Overactive Bladder Treatment Market Size
  • 2.2. Overactive Bladder Treatment Growth Trends by Regions
    • 2.2.1. Overactive Bladder Treatment Market Size by Regions (2019-2025)
    • 2.2.2. Overactive Bladder Treatment Market Share by Regions (2014-2019)
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers
    • 2.3.3. Market Challenges
    • 2.3.4. Porter's Five Forces Analysis

3. Market Share by Key Players

  • 3.1. Overactive Bladder Treatment Market Size by Players
    • 3.1.1. Global Overactive Bladder Treatment Revenue by Players (2018-2019)
    • 3.1.2. Global Overactive Bladder Treatment Revenue Market Share by Players (2018-2019)
    • 3.1.3. Global Overactive Bladder Treatment Market Concentration Ratio (CR5)
  • 3.2. Overactive Bladder Treatment Key Players Head office and Area Served
  • 3.3. Key Players Overactive Bladder Treatment Product/Solution/Service
  • 3.4. Date of Enter into Overactive Bladder Treatment Market

4. Breakdown Data by Type, Cause and Region

  • 4.1. Global Overactive Bladder Treatment Market Size by Type (2014-2019)
  • 4.2. Global Overactive Bladder Treatment Market Size by Cause (2014-2019)
  • 4.3. Global Overactive Bladder Treatment Market by Regions and Age
    • 4.3.1. Global Overactive Bladder Prevalence Rate by Regions and Age
    • 4.3.2. Global Overactive Bladder Diagnosis Rate by Regions and Age
    • 4.3.4. Global Overactive Bladder Average Medical Cost/Paint by Regions 2014-2019
    • 4.3.5. Global Overactive Bladder Average Share of Medical Devices (Value Basis) of Medical Expense 2014-2019
    • 4.3.6. Global Overactive Bladder Average Share of Medical Devices (Patient Number Basis) of Medical Expense 2014-2019
  • 4.4. Price of Drugs and Medical Devices

5. United States

  • 5.1. United States Overactive Bladder Treatment Market (2014-2019)
  • 5.2. Overactive Bladder Treatment Key Players in United States
  • 5.3. United States Overactive Bladder Treatment Market Size by Type
  • 5.4. United States Overactive Bladder Treatment Market Size by Cause
  • 5.5. United States Overactive Bladder Treatment Article/Regulation/Guideline

6. UK

  • 6.1. UK Overactive Bladder Treatment Market (2014-2019)
  • 6.2. Overactive Bladder Treatment Key Players in UK
  • 6.3. UK Overactive Bladder Treatment Market Size by Type
  • 6.4. UK Overactive Bladder Treatment Market Size by Cause
  • 6.5. UK Overactive Bladder Treatment Article/Regulation/Guideline

7. Germany

  • 7.1. Germany Overactive Bladder Treatment Market (2014-2019)
  • 7.2. Overactive Bladder Treatment Key Players in Germany
  • 7.3. Germany Overactive Bladder Treatment Market Size by Type
  • 7.4. Germany Overactive Bladder Treatment Market Size by Cause

8. France

  • 8.1. France Overactive Bladder Treatment Market (2014-2019)
  • 8.2. Overactive Bladder Treatment Key Players in France
  • 8.3. France Overactive Bladder Treatment Market Size by Type
  • 8.4. France Overactive Bladder Treatment Market Size by Cause
  • 8.5. France Overactive Bladder Treatment Article/Regulation/Guideline

9. Spain

  • 9.1. Spain Overactive Bladder Treatment Market (2014-2019)
  • 9.2. Overactive Bladder Treatment Key Players in Spain
  • 9.3. Spain Overactive Bladder Treatment Market Size by Type
  • 9.4. Spain Overactive Bladder Treatment Market Size by Cause

10. China

  • 10.1. China Overactive Bladder Treatment Market (2014-2019)
  • 10.2. Overactive Bladder Treatment Key Players in China
  • 10.3. China Overactive Bladder Treatment Market Size by Type
  • 10.4. China Overactive Bladder Treatment Market Size by Cause

11. Australia

  • 11.1. Australia Overactive Bladder Treatment Market (2014-2019)
  • 11.2. Overactive Bladder Treatment Key Players in Australia
  • 11.3. Australia Overactive Bladder Treatment Market Size by Type
  • 11.4. Australia Overactive Bladder Treatment Market Size by Cause
  • 11.5. Australia Overactive Bladder Treatment Article/Regulation/Guideline

12. Key Players Profiles

  • 12.1. Astellas Pharma
    • 12.1.1. Astellas Pharma Company Details
    • 12.1.2. Astellas Pharma Product Information
    • 12.1.3. Revenue and Gross Margin
  • 12.2. Allergan
    • 12.2.1. Allergan Company Details
    • 12.2.2. Allergan Product Information
    • 12.2.3. Revenue and Gross Margin
  • 12.3. Pfizer
    • 12.3.1. Pfizer Company Details
    • 12.3.2. Pfizer Product Information
    • 12.3.3. Revenue and Gross Margin
  • 12.4. Johnson & Johnson
    • 12.4.1. Johnson & Johnson Company Details
    • 12.4.2. Johnson & Johnson Product Information
    • 12.4.3. Revenue and Gross Margin
  • 12.5. Medtronic
    • 12.5.1. Medtronic Company Details
    • 12.5.2. Medtronic Product Information
    • 12.5.3. Revenue and Gross Margin
  • 12.6. Kyorin Pharmaceutical
    • 12.6.1. Kyorin Pharmaceutical Company Details
    • 12.6.2. Kyorin Pharmaceutical Product Information
    • 12.6.3. Revenue and Gross Margin

13. Market Forecast 2019-2025

  • 13.1. Market Size Forecast by Regions
  • 13.2. United States
  • 13.3. UK
  • 13.4. Germany
  • 13.5. France
  • 13.6. Spain
  • 13.7. China
  • 13.8. Australia
  • 13.9. Market Size Forecast by Product (2019-2025)
  • 13.10. Market Size Forecast by Cause (2019-2025)

14. Analyst's Viewpoints/Conclusions

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
    • 15.1.2. Data Source
  • 15.2. Disclaimer
  • 15.3. Author Details
Back to Top